The most familiar small-molecule PERK inhibitor, GSK2606414, which is said to be the first one with high specificity for this kinase, was successfully tested on HT-29 colon cancer cell culture and proven to reduce breast cancer cells metastasis in vivo [281,282]. The gene discussed is EIF2AK3; the disease is breast carcinoma.